Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 11/06/2024 9:48:45 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 11555
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
70996
So sorry to hear about Alan C. My sincere
(5)
Fit007
01/03/2022 12:18:40 PM
70995
I appreciated Alan Cs daily report on trading.
(3)
Jimvette
01/03/2022 11:02:19 AM
70994
AlanC regrettably passed away.
(2)
someconcerns
01/03/2022 9:59:49 AM
70993
Does anyone know whereabout AlanC?
Zadie
01/03/2022 7:30:45 AM
70992
Early, but new variant possibly greater than
(1)
djs7
01/02/2022 11:18:15 PM
70991
Let's pray Brilacidin can find its specific path
(1)
djs7
01/02/2022 10:19:43 PM
70987
Found this post on another site. Am currently
(7)
petemantx
12/30/2021 4:49:55 PM
70982
Hope everyone had a Merry Christmas and is
(7)
scgmck1
12/29/2021 10:25:24 PM
70980
Initially I was very disturbed with the PR
(8)
petemantx
12/27/2021 8:38:39 PM
70979
As frustrations mount over the need for, what
(2)
Commando911
12/27/2021 12:52:02 AM
70978
So if you have migraines or certain heart
(3)
Drano
12/27/2021 12:07:13 AM
70977
Ritonavir, part of part of Pfizer's covid pill
(5)
farrell
12/26/2021 11:43:01 PM
70976
Great post farrell. We have all read about safety
(6)
Mo
12/26/2021 11:49:20 AM
70975
At this point none of the other antiviral drugs
(11)
farrell
12/26/2021 10:59:11 AM
70972
Thanks and same to you and the board as well.
(3)
Kelt
12/25/2021 3:14:01 PM
70968
Second the motion. Merry Christmas and let's hope
(5)
Drano
12/25/2021 11:02:42 AM
70967
Merry Christmas to you and all who
(5)
someconcerns
12/25/2021 6:31:36 AM
70966
Merry Christmas, folks!
(5)
Commando911
12/24/2021 10:56:00 PM
70965
Maybe Leo will apply for a NIIMBL grant from the
Commando911
12/23/2021 10:04:23 AM
70961
Response to a post on another board. Post:
(3)
Kelt
12/21/2021 6:03:41 PM
70959
Good information. The "broad spectrum" potential
bandg
12/21/2021 9:14:37 AM
70958
Links:
(2)
farrell
12/21/2021 9:05:24 AM
70956
The multi-identity just wants to soft bash. But
(3)
Drano
12/20/2021 4:29:32 PM
70955
The "Fat Lady" hasn't sung yet on the P2 results
(5)
Kelt
12/20/2021 3:49:14 PM
70954
Brilacidin phase 2 test suggested they did not
(4)
airplaneguy
12/20/2021 3:06:09 PM
70953
With Regeneron's covid antiviral "antibiotic"
(12)
farrell
12/19/2021 12:10:14 AM
70952
IPIX has a distinct advantage over Galera and
(4)
bandg
12/16/2021 1:50:16 PM
70949
Nice soft-bashing. Galera's drug initially failed
(6)
Drano
12/16/2021 2:22:45 AM
70948
Lilly's Mirikizumab for UC. Galera's GC4419 for
(3)
bandg
12/15/2021 8:41:20 PM
70947
This is a fascinating read. it's no wonder that
(6)
Fit007
12/15/2021 8:00:18 AM
70946
GREAT Brilacidin link from another site. True
(5)
petemantx
12/14/2021 8:10:18 PM
70945
Agreed.
bandg
12/14/2021 6:33:15 PM
70944
That's quite the endorsement of B....that alone
(7)
Chemdeps
12/14/2021 5:57:12 PM
70943
Current university article with mention of
(4)
bandg
12/14/2021 5:34:30 PM
70941
Russian State Register of Medicines status,
(1)
crashco
12/13/2021 9:44:42 AM
70936
Thats easy, Drano. Because theres a whole
(10)
scgmck1
12/08/2021 9:50:42 PM
70934
Glad to see that the multi-identities are
(3)
Drano
12/08/2021 4:05:40 PM
70932
Seems logical that they would continue until
(1)
bandg
12/08/2021 3:09:05 PM
70931
hahaha he's having to sign in under several
(3)
Drano
12/08/2021 3:01:18 PM
70930
The big question I have is why multi-identities
(5)
Drano
12/08/2021 1:40:43 PM
70929
So the big question I have is...are doctors still
(3)
Chemdeps
12/08/2021 11:52:36 AM
70928
On what? Whom are you speaking
(2)
scgmck1
12/07/2021 9:28:33 PM
70927
$IPIX ICYMI
(1)
TonyCorvette
12/07/2021 7:38:14 AM
70925
I'd think any compassionate use analysis could
(1)
bandg
12/06/2021 7:03:33 PM
70923
Easy to find as to Remdesivir recommended
(1)
bandg
12/06/2021 5:39:36 PM
70922
Attached is an article I found online just now by
(3)
petemantx
12/06/2021 4:37:43 PM
70920
Pete, I believe the Yahoo author is incorrect
(11)
Mo
12/06/2021 1:24:24 PM
70915
I found this link on another site and what
(5)
petemantx
12/05/2021 9:25:04 AM
70914
I'd be bettinglarge on that one !!
(3)
Kelt
11/30/2021 10:20:53 PM
70912
How amusing that the scum multiple identity
(8)
Drano
11/30/2021 10:02:32 AM
Newer
Older
Recent Articles
Transforming the Events Industry: Rhuna Partners with Plume
ANI Pharmaceuticals Prepares for Piper Sandler Healthcare Conference
Ultragenyx Pharmaceutical's Upcoming Investor Conferences in December
Exela Technologies Outlines Plans for Upcoming Earnings Call
Cansortium Expands Financial Flexibility with New Credit Deal
Aclaris Therapeutics to Showcase Innovations at Major Conference
YXT.com Unveils Key Leadership Changes to Drive Growth
Mazarin Inc. Welcomes New CFO Amid Strategic Changes
Mazarin Inc. Grants Stock Options to Enhance Share Value
Autodesk Delivers Impressive Q3 Earnings Report
Nutanix Reports Strong Q1 Earnings Performance and Growth
Urbanfund Corp. Reports Impressive Financial Performance
Ambarella Inc Achieves Impressive Q3 Results, Stock Rises
Yelp Acquires RepairPal for Strategic Expansion in Services
TechTarget's Merger with Informa: A Game-Changer in B2B
Onco360 Partners with BrightSpring for Innovative Cancer Therapies
How Tariff Policies Shape Global Currencies and Markets
Impact of US Tariffs on Global Economic Growth Raises Concerns
Autodesk Surpasses Q3 Earnings Expectations with Key Metrics
X Financial Sees Growth in Q3 2024 Results Amid Strong Demand
Workday Reports Robust Q3 Earnings Performance and Growth
3D Systems Reports Q3 Earnings: Insights and Analysis
Minerals Technologies Strengthens Financial Position with New Loan
Couchbase Rewards New Employees with Equity Incentives
Join the Exciting December 2024 Shipping Webinars Today!
Newmont's Strategic Moves: Cashing in on Non-Core Assets
Partsol Partners with the US Army for Innovative AI Services
Lawmakers Urge Biden to Expand Cannabis Clemency Efforts
Humacyte, Inc. (HUMA) Faces Class Action in Major Legal Move
Autodesk Reports Q3 Earnings: Insights and Future Outlook
Legal Action Alert for Investors in Zeta Global Holdings, Corp.
Celsius Holdings, Inc. Class Action: Key Details for Investors
Investors Alerted: Class Action for Xerox Holdings Corporation
Workday's Q3 Performance Shows Resilience Amid Challenges
Evelyn Angelle Joins Bird Construction's Board of Directors
Supernus Pharmaceuticals Set for Engaging Healthcare Conference
Impact of Trump's Tariff Plans on Canadian Dollar and Peso
Investors Explore Class Action Against Paragon 28, Inc.
Unlocking Legal Insights: Join the Fight with Xerox Investors
Alison Voorhees Appointed as SVP and Marketing Director at Bank
Nutanix Achieves Impressive Growth in Q1 Fiscal 2025 Results
Autodesk Reports Strong Third Quarter Results for Fiscal 2025
Workday's Impressive Growth in Q3 and Future Prospects
Portage Biotech's Latest Financial Update Highlights Progress
Ambarella Reports Impressive Revenue Growth in Q3 2025
Urban Outfitters Achieves Impressive Q3 Revenue and Profit
Nordstrom Inc. Reports Strong Q3 Earnings and Growth Trends
Surprising Crude Inventory Drop Signals Strong Oil Demand Surge
Burlington Welcomes New Board Member, Former Staples CEO Shira Goodman
Minerals Technologies Secures Major Loan to Strengthen Growth